Secondary Logo

Editorial introductions

Current Opinion in Lipidology: December 2004 - Volume 15 - Issue 6 - p i-ii
Editorial introductions
Free

Current Opinion in Lipidology was launched in 1990. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of lipidology is divided into six sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.

Back to Top | Article Outline

Section Editors

Peter H Jones

Figure 1

Figure 1

Peter Howard Jones, MD, received his bachelor's degree in chemistry (summa cum laude, Phi Beta Kappa) at Washington and Lee University in Lexington, Virginia, and his medical degree (with highest honors and as the DeBakey Scholar) at the Baylor College of Medicine in Houston, Texas. He completed a residency in internal medicine at the Baylor Affiliated Hospitals and as Chief Medical Resident at Ben Taub General Hospital, both in Houston.

Dr. Jones is an Associate Professor in the Department of Medicine, Section of Atherosclerosis and Lipid Research at the Baylor College of Medicine. He also serves as Co director of the Lipid Metabolism and Atherosclerosis Clinic and Medical Director of the Weight Management Program for The Methodist Hospital Wellness Services, both in Houston.

A fellow of the American College of Physicians and the Council on Arteriosclerosis and Thrombosis of the American Heart Association, Dr. Jones is also a board member of and secretary for the National Lipid Association.

Dr. Jones has published numerous clinical abstracts, articles, and textbook chapters and has delivered presentations at many national and international symposia on topics ranging from drug therapy for dyslipidemias and new frontiers in lipid drug therapy to diabetic dyslipidemia and coronary heart disease.

Back to Top | Article Outline

Ruth McPherson

Figure 2

Figure 2

Dr. McPherson received a PhD in Nutritional Biochemistry from the University of London (UK) before completing medical studies at the University of Toronto, graduating Magna Cum Laude in 1984. She completed fellowship training in Internal Medicine and Endocrinology and Metabolism at the University of Toronto. She has held academic positions at the University of Toronto and McGill University and is currently Professor in the Departments of Medicine and Biochemistry and director of the Lipid Clinic at the University of Ottawa Heart Institute.

Dr. McPherson is a member of the CIHR Lipoprotein & Atherosclerosis Group at the University of Ottawa. Her laboratory research is centered on the genetic regulation of HDL receptors, including SR-BI, CETP and LRP and their role in cholesterol trafficking. She has had continuous support from peer-reviewed funding agencies including the National Institutes of Health (NIH), Medical Research Council (MRC), Canadian Institutes of Health Research (CIHR) and Heart & Stroke Foundation of Ontario (HSFO) since 1988. She has authored or co-authored several book chapters and over 75 peer-reviewed manuscripts. Dr. McPherson was awarded the Queen's Jubilee Medal in 2002 for her contributions to scientific research.

Dr. McPherson is also active in clinical research in the areas of atherothrombotic risk factors for coronary heart disease and the genetic etiology of obesity and obesity resistance. Ongoing work is directed at defining genetic risk factors for the metabolic sequelae of obesity including diabetes and dyslipidemia.

Dr. McPherson holds the Wyeth-Ayerst/CIHR Chair in Cardiovascular Disease in Women. She has served continuously over the last 10 years on grant review committees for the MRC/CIHR and HSFC. She is a member of the Editorial Board for the Journal of Lipid Research and of the Canadian Journal of Cardiology. Dr. McPherson is a member of the Health Canada Expert Panel on the Diagnosis and Treatment of Dyslipidemia and has been a strong advocate of strategies for the primary and secondary prevention of cardiovascular disease.

© 2004 Lippincott Williams & Wilkins, Inc.